Skip to content

CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.

CARE - Quality Development in Cardiovascular Disease in General Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00713960
Enrollment
2193
Registered
2008-07-14
Start date
2008-04-30
Completion date
2010-12-31
Last updated
2012-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

Quality development project, primary care nurses, cardiovascular disease, secondary prevention, follow-up

Brief summary

Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients in secondary prevention of cardiopathy (ischaemic heart disease, claudication intermittence, thrombotic apoplexy cerebri, diabetes) who are not followed in an outpatient department.

Exclusion criteria

* Patients who suffer from diabetic nephropathy will be excluded * According to the general practitioners appraisal, patients who suffer from severe co morbidity can be excluded as well.

Design outcomes

Primary

MeasureTime frame
Cholesterol, HDL -cholesterol, LDL-Cholesterol, Blood pressure, Exercise, Waist-circumference, BMI, Smoking status, fasting plasma-glucose, medication takenAs needed, min. baseline and after 6 months

Secondary

MeasureTime frame
Number of visits pr. patients, drop-outAnnually

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026